Rocket Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RCKT and other ETFs, options, and stocks.About RCKT
Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and devastating pediatric diseases. The firm's multi-platform development approach applies the lentiviral vector and adeno-associated viral vector gene therapy platforms.
RCKT Key Statistics
Stock Snapshot
As of today, Rocket Pharmaceuticals(RCKT) shares are valued at $2.65. The company's market cap stands at 281.02M, with a P/E ratio of -14.21.
As of 2026-10-10, Rocket Pharmaceuticals(RCKT) stock has fluctuated between $2.54 and $2.69. The current price stands at $2.65, placing the stock +4.3% above today's low and -1.5% off the high.
The Rocket Pharmaceuticals(RCKT)'s current trading volume is 3.37M, compared to an average daily volume of 2.28M.
In the last year, Rocket Pharmaceuticals(RCKT) shares hit a 52-week high of $5.45 and a 52-week low of $2.42.
In the last year, Rocket Pharmaceuticals(RCKT) shares hit a 52-week high of $5.45 and a 52-week low of $2.42.
RCKT News
Rocket Pharmaceuticals ( (RCKT) ) has issued an update. On September 30, 2026, Rocket Pharmaceuticals entered into a Loan and Security Agreement with Hercules...
Rocket Pharmaceuticals (RCKT) “announced that it has entered into a credit facility agreement with Hercules Capital (HTGC) for up to $150 million. The facility...
Analyst ratings
50%
of 14 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.